Interview: Janet Woodcock’s lasting influence on FDA
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyGenericsOTCPharmaceuticalsUnited StatesRegulatory NewsJoanne S. EglovitchBiologics/ biosimilars/ vaccinesBiotechnologyGenericsOTCPharmaceuticalsUnited States